Ripelocker LLC

Valent Biosciences Corporation

Yong-Ki Kim

George Frank Lobisser

Gregory D Venburg

Benjamin A Belkind

Zhengyu Huang

Robert Scott Fassel

Eric Levi

Ayyappan Nair

Andrew B Harrah

Ricardo I Diaz-Carcamo

Alexander Keith Tellekson

Thomas Owen Mitchell

Methods, apparatus, and system to measure and control respiration of a perishable commodity in a vacuum chamber, including for purposes of extending a shelf life of a perishable commodity therein, including.

Measurement and control of respiration of perishable commodities in low absolute pressure method, system, and apparatus

Methods, apparatus, and system for storing perishable products in a vacuum container. An atmosphere control system is coupled to the vacuum container for measuring and maintaining controlled atmospheric conditions within the vacuum container. The atmosphere control system includes a plurality of monitors configured to monitor atmospheric conditions within the vacuum container. The atmosphere control system further includes a vacuum pump configured to reduce total absolute pressure in the vacuum chamber to below a total gas pressure limit, an ozone generator configured to generate gaseous ozone, and an inlet valve coupled to the ozone generator and configured to admit an ozone-containing gas into the vacuum container.

System, apparatus, and method for ozone-containing vacuum storage of perishable products

The present invention generally relates to concentrated natamycin suspension formulations for inhibition of fungal growth. Specifically, the present invention relates to stable suspension concentrate formulations comprising from about 25% to about 48% w/w natamycin, from about 0.1% to about 10% w/w of an anionic surfactant selected from the group consisting of polyelectrolyte polymers, modified styrene acrylic polymers, dioctyl sodium sulfosuccinates, sodium salts of naphthalene sulfonates, and combinations thereof, and water. The formulations of the present invention contain natamycin as particles which are on average less than 11 microns in diameter and the formulations have a viscosity of less than 1400 centipoise at 21 degrees Celsius.

Concentrated natamycin suspension formulations

Growing community of inventors

Yakima, WA, United States of America

Yong-Ki Kim